Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17) Journal Article


Authors: Wiernik, P. H.; Sun, Z.; Gundacker, H.; Dewald, G.; Slovak, M. L.; Paietta, E.; Kim, H. T.; Appelbaum, F. R.; Cassileth, P. A.; Tallman, M. S.
Article Title: Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17)
Abstract: This retrospective study performed by the Eastern Cooperative Oncology Group and the Southwest Oncology Group enrolled 140 acute promyelocytic leukemia (APL) patients with t(15;17) to determine the influence of additional karyotypic abnormalities on treatment outcome. Karyotypes were centrally reviewed by both study groups. The complete response rate after induction for patients with t(15;17) treated with chemotherapy, or alltrans retinoic acid (ATRA) as induction therapy was not affected by additional cytogenetic aberrations. Disease-free (DFS) and overall survival (OS) were unaffected by additional cytogenetic abnormalities if treatment was chemotherapy without ATRA. Patients with t(15;17) only, treated with ATRA with or without chemotherapy, had an improved DFS (P = 0.06) and a better OS (P = 0.01) compared with ATRA-treated patients with additional cytogenetic abnormalities. Patients with APL and t(15;17) alone are significantly more sensitive to treatment with ATRA than are patients with t(15;17) and additional cytogenetic abnormalities. Copyright © Springer Science+Business Media, LLC 2012.
Keywords: adolescent; adult; cancer chemotherapy; cancer survival; treatment outcome; treatment response; aged; major clinical study; overall survival; disease free survival; retrospective study; chromosome aberration; promyelocytic leukemia; karyotype; retinoic acid; acute promyelocytic leukemia; all-trans retinoic acid; cancer prognosis; t(15; 17); de novo acute promyelocytic leukemia
Journal Title: Medical Oncology
Volume: 29
Issue: 3
ISSN: 1357-0560
Publisher: Humana Press Inc  
Date Published: 2012-09-01
Start Page: 2095
End Page: 2101
Language: English
DOI: 10.1007/s12032-012-0251-7
PROVIDER: scopus
PMCID: PMC3568758
PUBMED: 22729365
DOI/URL:
Notes: --- - "Export Date: 1 March 2013" - "CODEN: MONCE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Stuart Tallman
    649 Tallman